Columbia Asia Hospital - Tebrau

Through this article, Ts. Dr. James Chong explores the advancements of shearwave elastography (SWE) in assessing liver stiffness, emphasizing its non-invasive, reproducible, and radiation-free benefits. He highlights SWE’s relevance for chronic liver conditions prevalent in Asia, its cost-effectiveness, and expanded applications beyond the liver, including the thyroid and breast, enhancing diagnostic accuracy across specialties.

Introduction

Liver diseases, particularly those linked to viral infections like hepatitis B, pose significant public health challenges in Asia, where prevalence rates are higher than in other regions. Effective management and treatment of these conditions rely on an accurate assessment of liver stiffness. Shearwave elastography (SWE) has emerged as a transformative imaging technology for liver stiffness evaluation, offering a non-invasive, radiation-free, and reliable alternative for assessing liver fibrosis. This article delves into the advantages of SWE over traditional elastography techniques, its relevance for Asian liver imaging, image and data reproducibility, expanded clinical applications, and its use beyond the liver, including applications in the thyroid and breast.

Understanding Shearwave Elastography

Shearwave elastography (SWE) is an advanced imaging modality that quantifies liver stiffness by utilizing the principles of shear wave propagation. The technique generates shear waves directly within liver tissue, propagating at different speeds depending on tissue stiffness. By measuring propagation speed, clinicians can obtain quantitative values that accurately reflect liver stiffness and the severity of liver fibrosis.

Comparison with Traditional Elastography

SWE has significant advantages over traditional elastography methods, making it particularly valuable for liver imaging in Asia. Key benefits include:

1. Relevance to Asian Populations: In Asia, where chronic hepatitis B infections are more common, leading to increased risks of liver fibrosis and cirrhosis, SWE enables precise assessments of liver stiffness. The technique supports disease monitoring and allows for timely interventions and disease management,   essential for chronic liver conditions in these populations.

2. Reproducibility of Measurements: SWE provides highly reproducible data and images, enabling accurate longitudinal monitoring and reliable comparisons over time. This reproducibility supports clinicians in assessing disease progression and treatment response with confidence.

3. Non-Invasive and Radiation-Free: As a non-invasive and radiation-free tool, SWE is ideal for frequent follow-up assessments of liver disease, especially when repeated monitoring is required. Without radiation exposure, patients can undergo regular imaging without the associated health risks of cumulative radiation exposure.

Expanded Clinical Applications Beyond the Liver

In addition to liver stiffness assessment, SWE has proven helpful for imaging other organs, particularly the thyroid and breast, due to its ability to measure tissue stiffness non-invasively and provide quantitative data.

1. Thyroid Imaging: SWE has demonstrated promise in characterizing thyroid nodules by differentiating between benign and malignant lesions based on tissue stiffness. This allows clinicians to make more informed decisions regarding the need for invasive procedures like biopsies, thereby reducing unnecessary interventions.

2. Breast Imaging: SWE has also shown utility in breast imaging, which aids in assessing breast lesions. By distinguishing between benign and malignant lesions, SWE supports more accurate treatment planning and reduces the need for invasive biopsies. Moreover, SWE can monitor treatment responses in breast cancer patients, allowing timely adjustments to therapeutic regimens.

​Shearwave elastography is transforming liver health assessment in Asia, offering a non-invasive, reliable, and cost-effective solution that enhances diagnostic accuracy and reduces the need for invasive procedures

These expanded applications illustrate SWE’s versatility and potential as a supplementary imaging technique, enhancing diagnostic accuracy and minimizing invasive procedures.

Applications in Hepatology and Cost-Effectiveness

Beyond liver stiffness imaging, SWE has expanded clinical utility in hepatology, offering additional benefits and potential cost savings:

1. Differentiation of Liver Lesions: SWE assists in differentiating benign from malignant liver lesions by evaluating stiffness characteristics, providing critical information that guides treatment decisions and reduces unnecessary invasive procedures.

2. Assessment of NAFLD and NASH: With the increasing prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) due to global rises in obesity and metabolic syndrome, SWE offers a non-invasive, reliable method to evaluate liver fibrosis in these conditions. This capability is essential for risk stratification and determining timely interventions to prevent disease progression.

Cost-Effectiveness and Patient Benefits

SWE offers several cost-effective benefits that make it attractive for liver stiffness imaging, particularly in resource-limited settings where healthcare systems are burdened with high rates of chronic liver disease:

1. Reduced Need for Liver Biopsies: By providing reliable stiffness measurements, SWE minimizes the need for repeated liver biopsies, which are costly and carry risks. This non-invasive approach decreases overall healthcare costs while improving patient safety.

2. Longitudinal Monitoring: SWE allows for regular monitoring of liver stiffness, particularly in patients with chronic viral infections, where follow-up assessments are crucial. Early detection of changes in liver stiffness enables timely intervention, reducing the potential for long-term liver damage and associated healthcare costs.

3. Improved Patient Experience and Compliance: The non-invasive nature of SWE enhances patient compliance, as it allows for painless follow-up examinations without invasive procedures. This promotes early detection of liver fibrosis, enabling timely interventions and improved patient outcomes.

4. Resource Optimization: By consolidating liver stiffness assessments into a single non-invasive examination, SWE optimizes diagnostic resources, reduces wait times, and increases patient throughput, improving healthcare delivery efficiency.

Conclusion

Shearwave elastography represents a significant advancement in liver stiffness imaging, especially within Asian liver health contexts, where chronic viral hepatitis remains a prevalent issue. Its reproducibility, non-invasiveness, and quantitative capabilities enhance the accuracy of fibrosis assessment, while its expanded applications in thyroid and breast imaging underscore its versatility in various diagnostic settings. SWE’s ability to improve diagnostic accuracy and reduce the need for invasive procedures supports its value as a supplementary imaging modality.

As SWE technology continues to evolve, its non-invasive nature, reproducibility, and cost-effective benefits are poised to make it an invaluable tool across multiple specialties. By promoting early detection, timely interventions, and efficient healthcare practices, SWE contributes to improved patient outcomes and enhanced liver and other tissue-related disease management.